BL Pharmtech Corp. (KOSDAQ:065170)
South Korea · Delayed Price · Currency is KRW 1,823.00
-242.00 (-11.72%)
At close: May 29, 2026
BL Pharmtech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -15,189 | -16,778 | -5,706 | -148.85 | -13,903 | -20,211 |
Depreciation & Amortization | 486.44 | 556.32 | 852.35 | 848.1 | 900.55 | 3,448 |
Loss (Gain) From Sale of Assets | -4.23 | -2.79 | -78.66 | -52.54 | - | -3,032 |
Asset Writedown & Restructuring Costs | - | - | 950 | 2,900 | 5,151 | 16,238 |
Loss (Gain) From Sale of Investments | 3,262 | 3,262 | 180.06 | - | -283.8 | -67.11 |
Loss (Gain) on Equity Investments | 10,784 | 10,651 | 1,505 | 468.95 | 358.97 | - |
Stock-Based Compensation | 151.78 | 152.08 | -5.3 | 20.4 | 39.48 | 19.22 |
Provision & Write-off of Bad Debts | -3,522 | -2,584 | -593.47 | -124.14 | 65.09 | 191.72 |
Other Operating Activities | 2,911 | 3,007 | 140.48 | 3,823 | 4,946 | 7,437 |
Change in Accounts Receivable | -884.28 | -188.69 | 130.62 | -1,313 | 1,083 | -325.77 |
Change in Inventory | 718.04 | 1,090 | 854.11 | 7,741 | -3,320 | 314.38 |
Change in Accounts Payable | -57.23 | -88.31 | -674.82 | 1,514 | -2,906 | 1,776 |
Change in Other Net Operating Assets | -1,137 | 638.85 | -591.29 | -559.25 | -8,182 | -2,691 |
Operating Cash Flow | -2,480 | -283.76 | -3,037 | 7,992 | -10,998 | 3,097 |
Operating Cash Flow Growth | - | - | - | - | - | -46.64% |
Capital Expenditures | - | - | -1,166 | -312.07 | -1,708 | -587.15 |
Sale of Property, Plant & Equipment | - | - | - | 161.4 | - | 6,257 |
Divestitures | 1 | 1 | - | 26,264 | - | - |
Sale (Purchase) of Intangibles | -5.7 | -7.11 | -1,000 | -1.5 | -13.94 | -291.27 |
Investment in Securities | 1,851 | -39.33 | 3,714 | -10,817 | -1,459 | -7,102 |
Other Investing Activities | 6,553 | 6,553 | -8,051 | 0 | -192.02 | 2,045 |
Investing Cash Flow | 8,555 | 6,657 | -6,447 | 15,294 | -3,374 | 321.64 |
Short-Term Debt Issued | - | - | 1,000 | 24,388 | 11,388 | - |
Long-Term Debt Issued | - | 1,040 | - | 6,299 | 500 | 16,373 |
Total Debt Issued | 1,040 | 1,040 | 1,000 | 30,687 | 11,888 | 16,373 |
Short-Term Debt Repaid | - | - | - | -24,855 | -12,721 | -1,695 |
Long-Term Debt Repaid | - | -4,071 | -389.23 | -23,533 | -1,489 | -8,829 |
Total Debt Repaid | -4,081 | -4,071 | -389.23 | -48,389 | -14,210 | -10,523 |
Net Debt Issued (Repaid) | -3,041 | -3,032 | 610.77 | -17,702 | -2,322 | 5,850 |
Issuance of Common Stock | 0 | - | - | - | - | - |
Repurchase of Common Stock | - | -7.66 | -2 | - | - | -0.38 |
Other Financing Activities | -1.37 | -48.19 | 2,129 | 0 | - | -9.13 |
Financing Cash Flow | -3,042 | -3,088 | 2,738 | -17,702 | -2,322 | 5,840 |
Foreign Exchange Rate Adjustments | 0.82 | 1.66 | 3.01 | -0.46 | -35.05 | 113.13 |
Net Cash Flow | 3,033 | 3,287 | -6,743 | 5,584 | -16,728 | 9,372 |
Free Cash Flow | -2,480 | -283.76 | -4,203 | 7,680 | -12,706 | 2,510 |
Free Cash Flow Margin | -49.25% | -4.36% | -47.74% | 31.31% | -56.41% | 2.97% |
Free Cash Flow Per Share | -93.11 | -10.64 | -157.64 | 287.73 | -476.04 | 95.28 |
Cash Interest Paid | 279.97 | 313.54 | 356.19 | 1,491 | 930.47 | 925.5 |
Cash Income Tax Paid | - | -85.62 | 34.63 | -39.22 | -14.29 | -2.83 |
Levered Free Cash Flow | 1,595 | 2,068 | -7,744 | 7,260 | -11,273 | 4,183 |
Unlevered Free Cash Flow | 2,080 | 2,630 | -7,225 | 8,243 | -9,894 | 5,803 |
Change in Working Capital | -1,361 | 1,452 | -281.37 | 7,382 | -13,324 | -926.44 |